Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium hydroxide for postoperative ileus recovery after abdominal surgery
IRCT20130612013656N2Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- May 2026
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of Magnesium hydroxide in postoperative ileus (POI) (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Postoperative ileus improvement, Passage of gas and 3 more. Started May 2026; status: completed.
02
Drugs
Magnesium hydroxide
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on IRCT20130612013656N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130612013656N2.